13 results
10-Q
2020 Q3
ONCR
Oncorus, Inc.
12 Nov 20
Quarterly report
8:01am
the sale of the product in that country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product
10-K
2020 FY
ONCR
Oncorus, Inc.
10 Mar 21
Annual report
4:12pm
the revenues we are able to generate from the sale of the product in that country. Adverse pricing limitations may hinder our ability to recoup our investment
DRS/A
ONCR
Oncorus, Inc.
20 Dec 19
Draft registration statement (amended)
12:00am
the sale of the product in that country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates
424B4
kqr6e7ta1 wy
12 Feb 21
Prospectus supplement with pricing info
4:23pm
DRS
q14 eernouo
31 Oct 19
Draft registration statement
12:00am
S-1
xnzpwrxt6u8 tfzr01qo
11 Sep 20
IPO registration
4:49pm
DRS/A
f553xd
26 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
3sz fowjup
29 Jul 20
Draft registration statement (amended)
12:00am
424B4
x1zkb75
2 Oct 20
Prospectus supplement with pricing info
12:00am
DRS
714cm5 de1m
28 Jan 21
Draft registration statement
12:00am
- Prev
- 1
- Next